Underwood, Mark R.

Top Publications

Top Publications Authored or Co-Authored by "Underwood, Mark R."

• Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: Week 48 results from the randomised, double-blind, non-inferiority SAILING study

  The Lancet, Volume 382, No. 9893, Year 2013, Citations 477
• Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

  The Lancet, Volume 393, No. 10167, Year 2019, Citations 249
• Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

  The Lancet Infectious Diseases, Volume 19, No. 3, Year 2019, Citations 108
• Efficacy of second-line dolutegravir plus 2 nucleoside reverse transcriptase inhibitors by baseline nucleoside reverse transcriptase inhibitor resistance and nucleoside reverse transcriptase inhibitor use in the DAWNING study

  Antiviral Therapy, Volume 27, No. 1, Year 2022, Citations 9